(2465) O-serotype Distribution of Escherichia coli Causing Invasive Disease in Tertiary Care Hospital Patients

Scientific Director, Head Molecular Bacteriology & Bacterial Epidemiology
Janssen Vaccines & Prevention BV
Leiden, Zuid-Holland, Netherlands

Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica
Beerse, Antwerpen, Belgium

Hospital University Reina Sofia; University of Cordoba
Cordoba, Andalucia, Spain

Janssen Vaccines
Bern, Bern, Switzerland

Assistant Professor
University of Toronto
Toronto, ON, Canada

Director of Infectious Diseases Research
William Beaumont University Hospital, Corewell Health
Royal Oak, Michigan, United States

Julius Center for Health Sciences and Primary Care, University Medical Center
Utrecht, Utrecht, Netherlands

CIC1435, CHU Limoges
Limoges, Limousin, France

Bretonneau Hospital, Tours University Hospital Centre, University of Tours-INRAE
Tours, Centre, France

Assistant Professor
Duke University School of Medicine
Durham, NC, United States

Associate Director
Janssen Research & Development
Raritan, New Jersey, United States

Senior Scientific Director Biostatistics
Janssen Research & Development, Infectious Diseases & Vaccines, Janssen Pharmaceutica
Beerse, Antwerpen, Belgium

Janssen Research & Development
Raritan, New Jersey, United States

Justuf Liebeg University Diessen
Diessen, Hessen, Germany

Chief Professor
International University of Health and Welfare
Narita-shi, Chiba, Japan

Julius Center for Health Sciences and Primary Care, University Medical Center
Utrecht, Utrecht, Netherlands

Medical Leader VX Bern Clin
Janssen Research & Development, Janssen Vaccines
Bern, Bern, Switzerland

VP Bacterial Vaccines
Bacterial Vaccines Discovery and Early Development, Janssen Vaccines & Prevention B.V.
Leiden, Zuid-Holland, Netherlands